310 related articles for article (PubMed ID: 22287575)
1. Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats.
Sun Q; Kawamura T; Masutani K; Peng X; Sun Q; Stolz DB; Pribis JP; Billiar TR; Sun X; Bermudez CA; Toyoda Y; Nakao A
Cardiovasc Res; 2012 Apr; 94(1):144-53. PubMed ID: 22287575
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo carbon monoxide delivery inhibits intimal hyperplasia in arterialized vein grafts.
Nakao A; Huang CS; Stolz DB; Wang Y; Franks JM; Tochigi N; Billiar TR; Toyoda Y; Tzeng E; McCurry KR
Cardiovasc Res; 2011 Feb; 89(2):457-63. PubMed ID: 20851811
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts.
Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S
Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923
[TBL] [Abstract][Full Text] [Related]
4. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
5. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen-supplemented drinking water protects cardiac allografts from inflammation-associated deterioration.
Noda K; Tanaka Y; Shigemura N; Kawamura T; Wang Y; Masutani K; Sun X; Toyoda Y; Bermudez CA; Nakao A
Transpl Int; 2012 Dec; 25(12):1213-22. PubMed ID: 22891787
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant therapy reverses impaired graft healing in hypercholesterolemic rabbits.
Rosenbaum MA; Miyazaki K; Colles SM; Graham LM
J Vasc Surg; 2010 Jan; 51(1):184-93. PubMed ID: 19939614
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-α/NF-κB pathway.
Qin ZX; Yu P; Qian DH; Song MB; Tan H; Yu Y; Li W; Wang H; Liu J; Wang Q; Sun XJ; Jiang H; Zhu JK; Lu W; Huang L
Atherosclerosis; 2012 Feb; 220(2):343-50. PubMed ID: 22153150
[TBL] [Abstract][Full Text] [Related]
9. Do storage solutions protect endothelial function of arterialized vein graft in an experimental rat model?
Fouquet O; Blossier JD; Dang Van S; Robert P; Barbelivien A; Pinaud F; Binuani P; Eid M; Henrion D; Baufreton C; Loufrani L
J Cardiothorac Surg; 2020 Feb; 15(1):34. PubMed ID: 32041642
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Mitogen Activated Protein Kinase Activated Protein Kinase II with MMI-0100 reduces intimal hyperplasia ex vivo and in vivo.
Muto A; Panitch A; Kim N; Park K; Komalavilas P; Brophy CM; Dardik A
Vascul Pharmacol; 2012; 56(1-2):47-55. PubMed ID: 22024359
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.
Kallenbach K; Salcher R; Heim A; Karck M; Mignatti P; Haverich A
J Vasc Surg; 2009 Mar; 49(3):750-8. PubMed ID: 19268777
[TBL] [Abstract][Full Text] [Related]
12. Reduction of vein graft disease using photodynamic therapy with motexafin lutetium in a rodent isograft model.
Yamaguchi A; Woodburn KW; Hayase M; Robbins RC
Circulation; 2000 Nov; 102(19 Suppl 3):III275-80. PubMed ID: 11082401
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
14. Progression and regression of myointimal hyperplasia in experimental vein grafts depends on platelet-derived growth factor and basic fibroblastic growth factor production.
Sterpetti AV; Cucina A; Lepidi S; Randone B; Stipa F; Aromatario C; Travi D; D'Angelo LS; Cavallaro A; Stipa S
J Vasc Surg; 1996 Apr; 23(4):568-75. PubMed ID: 8627890
[TBL] [Abstract][Full Text] [Related]
15. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia.
Zhou N; Yu QJ; Si R; Gao HK; Wang T; Gao F; Wang HC; Bian JF
J Cardiovasc Pharmacol; 2010 Oct; 56(4):402-12. PubMed ID: 20625311
[TBL] [Abstract][Full Text] [Related]
16. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
[TBL] [Abstract][Full Text] [Related]
17. Use of Brilliant Blue FCF during vein graft preparation inhibits intimal hyperplasia.
Osgood MJ; Sexton K; Voskresensky I; Hocking K; Song J; Komalavilas P; Brophy C; Cheung-Flynn J
J Vasc Surg; 2016 Aug; 64(2):471-478. PubMed ID: 27763268
[TBL] [Abstract][Full Text] [Related]
18. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
[TBL] [Abstract][Full Text] [Related]
19. Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization.
Ji Y; Adeola O; Strawn TL; Jeong SS; Chen R; Fay WP
J Thromb Haemost; 2017 Apr; 15(4):814-825. PubMed ID: 28079982
[TBL] [Abstract][Full Text] [Related]
20. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
